Testing STIs to Improve PrEP Use in Pregnancy
Part of Infections clinical trials.
This trial tests whether STI testing during pregnancy helps more women start and stay on PrEP (a daily pill that prevents HIV). If you join, you'll help find better ways to protect both mother and baby from HIV.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are pregnant and going for antenatal (pregnancy) care
- You are a cis-gender woman (you identify with the sex you were assigned at birth)
- You do not have HIV
- You are not currently taking PrEP (a daily HIV prevention pill)
- You plan to stay in this city or town for your pregnancy care and for 9 months after delivery
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a program to help women at risk for HIV get PrEP, a medicine that prevents HIV. It focuses on women who may want to have a child or have been pregnant recently.
This study helps connect young people aged 13–24 to PrEP, a daily pill that prevents HIV. It tests whether offering PrEP in clinics or community locations makes it easier for you to get and stay on this prevention medication.
This study checks if routine testing for sexually transmitted infections (STIs) during early pregnancy can improve health for you and your baby. Participation involves a simple screening test at your first prenatal visit.
This study tests if combining sexually transmitted infection (STI) testing with HIV prevention medication (PrEP) helps control the HIV epidemic. It is for sexually active women aged 15-39 who live in Rakai and recently participated in a community health survey.
This study tests whether offering PrEP counseling to women with a recent STI at family planning clinics helps them start HIV prevention. Women who test positive for syphilis, gonorrhea, or chlamydia may be offered PrEP information and support.
This study in Zimbabwe tests a program to help pregnant women start and stay on PrEP (medication that prevents HIV). It aims to make PrEP easier to use during pregnancy for women who are at risk of HIV.
Hear when a new PrEP Adherence trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.